Today: 21 May 2026
Ucore Rare Metals stock dives nearly 15% into weekend as rare-earth pricing talks loom
1 February 2026
1 min read

Ucore Rare Metals stock dives nearly 15% into weekend as rare-earth pricing talks loom

Toronto, Feb 1, 2026, 12:53 EST — Market closed.

  • On Friday, Ucore Rare Metals dropped 14.6% on the TSX Venture Exchange
  • U.S. officials are set to hold allied discussions on stabilizing rare-earth prices next week
  • Traders are watching for updates following the Jan. 31 debt and warrant deadlines highlighted in earlier disclosures

Ucore Rare Metals fell 14.6% Friday, closing at C$8.36 on the TSX Venture Exchange. The stock had gained early, hitting C$9.50 before sliding to a session low of C$8.28.

The move matters because Washington is once again exploring ways to stabilize rare-earth prices — a factor that can make or break financing plans for smaller miners and potential processors. U.S. Under Secretary of State for Economic Affairs Jacob Helberg said officials plan to push for an agreement with allies on a pricing mechanism during next week’s meetings in Washington, describing it as an effort to “ensure price stability” for refiners and extractors. Bloomberg.com

Rare earths, essential in permanent magnets, electronics, and defense systems, often see volatile price swings. Numerous Western projects remain in the testing phase, struggling to compete with cheaper sources.

Friday’s decline marked the end of a volatile week for Ucore, which hit a peak of C$10.29 on Jan. 26 before retreating in the last days of the month, according to Yahoo Finance data.

On Friday, Ucore’s UURAF shares closed at $6.13 in U.S. over-the-counter trading, after swinging between $7.17 and $6.10, Yahoo Finance reports.

Ucore hasn’t updated its website with any new press releases since Jan. 15, so investors are left to watch sector news and adjust their positions heading into February.

Some investors are eyeing end-of-January deadlines noted in earlier filings. Ucore previously indicated certain convertible debentures mature on Jan. 31, 2026. The company also revealed warrants tied to revised debt deals that expire that same day.

The company announced plans for a rare-earth processing plant in Louisiana, employing its RapidSX separation technology. It frames the project as a move to boost non-China processing capacity.

Still, plenty can derail the process. Setting up any cross-border “pricing mechanism” might take longer than expected, face political pushback, or hit budget constraints. For early-stage firms, those delays are costly—they need capital and clear agreements with customers and governments to move forward.

On Monday (Feb. 2), eyes will be on Ucore to see if it steadies after Friday’s drop, with traders also looking out for updates on the late-January debt and warrant deadlines. Washington’s allied talks on rare-earth pricing could add to the news flow.

Stock Market Today

  • Thales (ENXTPA:HO) Shares Decline but DCF Model Indicates Undervaluation
    May 21, 2026, 1:56 AM EDT. Shares of Thales (ENXTPA:HO) have fallen 12.8% over the past month and are down 9.7% year on year, despite strong long-term returns of 79.2% and 203.0% over three and five years respectively. Recent sector-specific developments in aerospace and defense, alongside broader market sentiment, contribute to price volatility. A discounted cash flow (DCF) analysis estimates Thales's intrinsic value at around €306.76 per share, suggesting the current price of €229.50 trades at a 25.2% discount and that the stock is undervalued. The P/E ratio remains a key metric but further valuation aspects need evaluation, as Thales scores 4 out of 6 on Simply Wall St's valuation checks. Investors should consider these factors when assessing the stock's potential.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
HSBC share price near a 52-week high: what to watch before London opens
Previous Story

HSBC share price near a 52-week high: what to watch before London opens

Novo Nordisk stock heads into earnings week as Wegovy pill scripts top 26,000
Next Story

Novo Nordisk stock heads into earnings week as Wegovy pill scripts top 26,000

Go toTop